Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 835-840

  Jimenez S ^a   Tassies D ^a   Espinosa, G ^a   Garcia Criado A ^a   Plaza, J ^a   Monteagudo, J ^a   Cervera, Ricard ^a   Reverter, J C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; VERY LATE ACTIVATION ANTIGEN 2;

ADULT; ALLELE; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; ARTERY THROMBOSIS; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THICKNESS; THROMBOGENESIS; TUNICA MEDIA; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ANALYSIS OF VARIANCE; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTEGRIN ALPHA2; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOSIS;

EID: 45149103015     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077321     Document Type: Article

References (37)

1. Reverter JC, Tàssies D, Font J, Khamashta M, Chikawa K, Cervera R, et al. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum 1998;41:1420-7.
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
3. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002;196:887-96.
4. Jiménez S, Garcia-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 2005;44:756-61.
5. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost 1995;74:345- 51.
6. Ishida F, Fyrihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, et al. The largest variant of platelet glycoprotein Ib-alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine. Blood 1995;86:1356-60.
7. Moroi M, Jung SM, Yoshida N. Genetic polymorphism of platelet glycoprotein Ib. Blood 1984;64:622-9.
8. González-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, et al. Polymorphism of platelet membrane glycoprotein Ib-alfa associated with arterial thrombotic disease. Blood 1998;92:2771-6.
9. a and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 1998;18:1124-31.
10. Kunicki T, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin alpha2-beta1 density is associated with two silent polymorphisms in the alpha2 gene coding sequence. Blood 1997;89:1939-43.
11. Moshfegh K, Wuillemin WA, Redondo M, Lammle E, Beer JH, Liechti-Gallati S, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999;353:351-4.
12. Goldschmidt-Clermont PJ, Coleman LD, Pham YM, Cooke GE, Shear WS, Weiss EJ, et al. Higher prevalence of GP IIIa P1A2 polymorphism in siblings of patients with premature coronary heart disease. Arch Pathol Lab Med 1999;123:1223-9.
13. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997;350:1217-19.
14. Zhu MM, Weedon J, Clark LT. Meta-analysis of the association of platelet glycoprotein IIIa P1A1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000;86:1000-5.
15. Di Castelnuovo A, deGaetano G, Donati MB, Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism P1A1/A2 and coronary risk: a meta-analysis. Thromb Haemost 2001;85:626-33.
16. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
18. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: an update. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74: 1185-90.
19. Wang MX, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, et al. Epitope specificity of monoclonal anti-beta 2 glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J Immunol 1995;155:1629-36.
20. Jin Y, Dietz HC, Nurden A, Bray PF. Single-Strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993;82:2281-8.
21. Voetsch b., Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol 2004;24:216-29.
22. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The alfa2 gene coding sequence Y807/A873 of the platelet collagen receptor integrin alfa2beta1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999;93:3583-6.
23. Santoso S, Kinicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia 807 T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999;93:2449-53.
24. Roest M, Banga JD, Grobbee DE, de Groot PG, Sixma JJ, Tempelman MJ, et al. Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high risk women. Circulation 2000;102:1645-50.
25. Morita H, Kurihara H, Imai Y, Sugiyama T, Hamada C, Sakai E, et al. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese: an approach entailing meeting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 2001;85:226-30.
26. Croft SA, Hampton KK, Sorrell JA, Steeds RP, Channer KS, Samani NJ, et al. The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk facto for myocardial infarction. B J Haematol 1999;160:771-6.
27. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090- 4.
28. Tolusso B, Fabris M, Gremese E, Mosca M, Rovere-Querini P, Ferraccioli GF. Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association. Ann Rheum Dis 2003;62:781-2.
29. Van de Walle GR, Schoolmeester A, Iserbyt BF, Cosemans J, Heemskerk J, Hoylaerts MF, et al. Activation of alfaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alfa2beta1 on platelets. Blood 207;109:595-602.
30. Pontiggia L, Lasila R, Pederiva S, Hans-Rudolf S, Burger M, Beer JH. Increased platelet-collagen interaction associated with double homozygosity for receptor polymorphism of platelet GPIa and GPIIIa. Artherioscler Thromb Vasc Biol 2002;22:2093-8.
31. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
32. Lusis AJ. Atherosclerosis. Nature 2000;407:233-41.
33. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmermman GA, et al. Activated platelet mediate inflammatory signaling by regulated interleukin 1 beta synthesis. J Cell Biol 2001;154:485-90.
34. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Circulation 2000;148:75-85.
35. McEven R. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001;86:746-56.
36. Massberg S, Enders G, Matos FC, Tomic LI, Leiderer S, Eisenmerger K, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999;94:3829-38.
37. Henn V, Slupsky JR, Grafe M, Anagnostopoulus R, Foster G, Müller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.